21 October 2020 - Late treatment study
Hydroxychloroquine in mild-to-moderate COVID-19: a placebo-controlled double blind trial
et al., Clinical Microbiology and Infection, doi:10.1016/j.cmi.2021.03.005 (preprint 10/21) (Peer Reviewed)
Small early terminated late stage (60% on oxygen) RCT in France showing 46% lower mortality.mortality at 28 days relative risk RR 0.54 [0.21-1.42]
combined mortality/intubation at 28 days relative risk RR 0.74 [0.33-1.70]If not stopped early and the same trend continued, statistical significance would be reached on 28 day mortality after ~550 patients (1,300 patients were planned).Mortality results are not provided for subgroups. For the subgroups receiving AZ:No safety concerns were identified. This study has been presented as negative, however the results do not support that conclusion.NCT04325893
combined mortality/intubation at 28 days relative risk RR 0.74 [0.33-1.70]If not stopped early and the same trend continued, statistical significance would be reached on 28 day mortality after ~550 patients (1,300 patients were planned).Mortality results are not provided for subgroups. For the subgroups receiving AZ:No safety concerns were identified. This study has been presented as negative, however the results do not support that conclusion.NCT04325893
|
risk of death at day 28, 46.0% lower, RR 0.54, p = 0.21, treatment 6 of 124 (4.8%), control 11 of 123 (8.9%), NNT 24.
|
|
risk of combined intubation/death at day 28, 26.0% lower, RR 0.74, p = 0.48, treatment 9 of 124 (7.3%), control 12 of 123 (9.8%), NNT 40.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. |
Dubee et al., 10/21/2020, Randomized Controlled Trial, France, Europe, peer-reviewed, median age 77.0, 18 authors, average treatment delay 5.0 days.
Please send us
corrections, updates, or comments. Vaccines and treatments are both
valuable and complementary. All practical, effective, and safe means
should be used. Elimination of COVID-19 is a race against viral evolution. No
treatment, vaccine, or intervention is 100% available and effective for all
current and future variants. Denying the efficacy of any method increases
mortality, morbidity, collateral damage, and the risk of endemic status. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. WCH
and FLCCC provide
treatment protocols.